This report summarizes FDA’s performance results in meeting its ADUFA goals and commitments for FY 2022 and FY 2023. Specifically, it updates and finalizes performance data initially reported in the FY 2022 ADUFA Performance Report and presents preliminary data on FDA’s progress in meeting its FY 2023 review goals, implementation activities, and accomplishments
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
Food and Drug Administration, Health and Human Services Department.
"Performance Report to Congress: Animal Drug User Fee Act FY 2023". Government.
Health and Human Services Department, Food and Drug Administration,
January 30, 2024.
https://www.govinfo.gov/app/details/CMR-HE20_4000-00195363
APA
Food and Drug Administration, Health and Human Services Department.
(2024, January 30).
Performance Report to Congress: Animal Drug User Fee Act FY 2023.
[Government].
Health and Human Services Department, Food and Drug Administration.
https://www.govinfo.gov/app/details/CMR-HE20_4000-00195363
MLA
Food and Drug Administration, Health and Human Services Department.
Performance Report to Congress: Animal Drug User Fee Act FY 2023.
Health and Human Services Department, Food and Drug Administration,
(30 Jan 2024),
https://www.govinfo.gov/app/details/CMR-HE20_4000-00195363
Bluebook
Food and Drug Administration, Health and Human Services Department, Performance Report to Congress: Animal Drug User Fee Act FY 2023, GovInfo, (January 30, 2024),
https://www.govinfo.gov/app/details/CMR-HE20_4000-00195363
